COMMD2 is a scaffold protein within the commander complex that facilitates endosomal recycling of transmembrane cargos by integrating the CCC and retriever subcomplexes 1. Beyond its canonical recycling function, COMMD2 may modulate cullin-RING E3 ubiquitin ligase activity and regulate NF-κB signaling 2. COMMD2 interacts with the epithelial sodium channel (ENaC) to regulate its cell surface expression and sodium transport, functioning alongside other COMM domain-containing family members as an endogenous regulator 3. In disease contexts, COMMD2 emerges as a significant biomarker across multiple pathologies. It is identified as a shared diagnostic marker between primary Sjögren's syndrome and chr3 kidney disease, with expression associated with immune cell infiltration patterns 4. COMMD2 shows elevated expression in hepatocellular carcinoma (HCC) and is negatively correlated with overall survival, functioning as an independent prognostic factor for poor outcomes 5. Pan-cancer analysis reveals COMMD2 upregulation correlates with unfavorable prognosis, tumor stemness, and immune cell infiltration across multiple malignancies 6. In HCC specifically, ncRNA-mediated COMMD2 upregulation associates with progression and immune checkpoint expression 7. These findings position COMMD2 as both a functional regulator of cellular trafficking and a significant oncogenic marker with therapeutic potential.